Silence Therapeutics plc · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±1.1%implied · straddle

19.5419.96

spot 19.75exp Nov 20ATM strike 20ATM straddle 0.25IV 3%

Oct 30 close

Expected move

Inputs

Implied vs realized

History

No reported quarters.

Bull & bear

Nov 5 report · est.

—

Linked exposure

SLN report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 22impliedImplied move: ±1.6% into Nov 5 earnings (Oct 22 close).Source

Oct 198-KMaterial agreement: Transaction Agreement with Merck KGaA, Darmstadt, Germany, a German corporation with general partners (" Purchaser ").Source

Oct 19haltTrading halt: 07:55 ET, resumed 08:20 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.